Ryder System (R) Stock

EdgeTI helps digital business units stand out and improve efficiency and growth by using digital twins. The company, based in Arlington, Virginia, has been acknowledged by Gartner as a key technology provider for these units. Gartner describes digital business units as parts of a company that create new digital businesses for traditional industries like manufacturing or healthcare.

TORONTO, ON / ACCESS Newswire / January 27, 2025 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a pharmaceutical company focused on developing light, radiation, sound, and drug-activated small molecules for treating various cancers, bacteria, and viruses, is excited to share that its interim clinical data will be presented at the American Urological Association ("AUA") Annual Meeting. The AUA Program Committee has accepted Theralase®'s abstract titled: "Interim Analysis of Light-Activated TLD-1433 in a Phase II Clinical Study of BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma In-Situ" for a Podium Session at the 2025 AUA Annual Meeting, which will take place in Las Vegas, Nevada, from April 26th to 29th.

Nitches Inc. (OTC PINK:NICH) has announced its partnership with GovX, offering a 30% discount and continued support for veterans and first responders. The company, InTheZoneLabs®, shared positive feedback from service members who have benefited from their nootropic supplements, which enhance mental clarity, focus, and sleep. Their products contain scientifically proven ingredients such as L-theanine and lion's mane mushroom, aiming to provide a safer alternative to some prescription medications.

HALIFAX, NS / ACCESS Newswire / January 21, 2025 / MedMira Inc. (MedMira) (TSXV:MIR) has announced that it has obtained Investigational Testing Authorizations (ITAs) from Health Canada to start clinical trials for new label claims for its recently approved Multiplo® TP/HIV rapid test. These new claims will allow the test to be used as a self-test and by non-professionals, which will increase access to testing for syphilis and HIV in Canada.

LAVAL, QC / ACCESS Newswire / January 17, 2025 / Bausch Health Companies Inc. and its gastroenterology division, Salix Pharmaceuticals, have announced that the Centers for Medicare and Medicaid Services (CMS) has chosen XIFAXAN® (rifaximin) 550 mg tablets for the second round of negotiations under the Inflation Reduction Act, with a price starting in 2027. The company is eager to have open discussions with CMS to highlight the benefits of XIFAXAN® for the healthcare system, along with endorsements from The American Association for the Study of Liver Diseases and the European Association for the Study of the Liver, which rated it highly in their guidelines.

The documentary, produced by Bad Robot, Glen Powell's Barnstorm Productions, Zipper Bros Films, IMAX Entertainment, and Dolphin Entertainment, earned over $2 million at the box office and topped the charts on Prime Video when it was released last summer. For more than 75 years, the Blue Angels have captivated audiences both in the U.S. and worldwide. IMAX Entertainment and Dolphin Entertainment are excited to offer a new 3D version of "The Blue Angels," allowing viewers to experience the Navy's elite Flight Demonstration Squadron like never before.

HALIFAX, NS / ACCESSWIRE / January 14, 2025 / MedMira Inc. (MedMira) (TSXV:MIR) announced that it has received approval from Health Canada for its Reveal® Rapid G4 HIV-1/2 Test (Reveal® HIV test) for Point-of-Care (POC) use. This rapid test has a sensitivity of 99.64% and a specificity of 99.71%, making it an excellent choice for healthcare professionals who need quick, dependable, and high-quality results in any medical environment.

Oral DehydraTECH-tirzepatide showed a 47% decrease in adverse events compared to the injected Zepbound® in a study. While the injected version resulted in 38 adverse events among 9 participants, the oral version only caused 20. Additionally, both forms were similar in their effectiveness for lowering blood glucose and insulin secretion levels.

LOS ANGELES, CA / ACCESSWIRE / January 14, 2025 / General Enterprise Ventures, Inc. (OTC PINK:GEVI), a leader in sustainable fire protection, along with its subsidiary, Mighty Fire Breaker®, LLC (MFB), expresses heartfelt condolences to those impacted by the recent wildfires in Los Angeles. To help these communities, we are starting a charitable program that includes donating our patented, EPA-certified fire inhibitor, CitroTech®, to homeowners in areas at high risk, offering better protection against future fires.